CODA Earnings

CODA reported its earnings on 2026-06-15, showcasing a revenue of 6.90M against an estimate of 7.52M, resulting in a -8.24% surprise. The EPS was 0.15, surpassing the expected 0.13 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CODA's earnings announcement on 2026-06-15, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, CODA's stock price tends to shift by an average of 14.88% in the 10 days leading up to earnings and 1.66% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate CODA's annual revenue to reach 7.96M, while the EPS is projected at 0.14. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CODA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CODA's stock price typically moves by 14.88% in the 10 days before its earnings and 1.66% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of 0.14 and revenue of 7.96M.

The earnings call summary shows strong financial performance with a 28.8% revenue increase and positive growth across all business units. The Q&A section reveals ongoing product developments and encouraging integration into new platforms, despite some uncertainty in market sizing. The company's strategy for revenue growth through technology adoption and defense sector expansion is promising. Although there are challenges in scaling the Echoscope product, the overall outlook is positive due to strong financials and growth opportunities, suggesting a stock price increase of 2% to 8% over the next two weeks.